Show simple item record

Apparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes

dc.contributor.authorKOROGLU, Bayram
dc.contributor.authorKARAGÖZ, Ahmet
dc.contributor.authorYuksel, Murat
dc.contributor.authorAydin, Mesut
dc.contributor.authorOnat, Altan
dc.contributor.authorCan, Günay
dc.date.accessioned2021-03-04T17:39:42Z
dc.date.available2021-03-04T17:39:42Z
dc.date.issued2014
dc.identifier.citationOnat A., KOROGLU B., Can G., KARAGÖZ A., Yuksel M., Aydin M., "Apparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes", ANATOLIAN JOURNAL OF CARDIOLOGY, cilt.14, sa.1, ss.26-33, 2014
dc.identifier.issn2149-2263
dc.identifier.othervv_1032021
dc.identifier.otherav_86a037e2-1ff9-4148-a3de-5edb26575db1
dc.identifier.urihttp://hdl.handle.net/20.500.12627/91493
dc.identifier.urihttps://doi.org/10.5152/akd.2013.5009
dc.description.abstractObjective: We investigated the association of serum asymmetric dimethylarginine (ADMA) with metabolic syndrome (MetS), type-2 diabetes and coronary heart disease (CHD) in the general population.
dc.language.isoeng
dc.subjectTıp
dc.subjectDahili Tıp Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectKardiyoloji
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectCARDIAC ve CARDIOVASCULAR SİSTEMLER
dc.titleApparently "low" serum asymmetric dimethylarginine is associated with fasting glucose and tends toward association with type-2 diabetes
dc.typeMakale
dc.relation.journalANATOLIAN JOURNAL OF CARDIOLOGY
dc.contributor.departmentAnkara Numune Training & Research Hospital , ,
dc.identifier.volume14
dc.identifier.issue1
dc.identifier.startpage26
dc.identifier.endpage33
dc.contributor.firstauthorID90801


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record